1. Market Research
  2. > Healthcare
  3. > Health Services Market Trends
  4. > Health Services Industry 2022 - Asia Market Research & Statistics

Health Services Industry 2022 - Asia Market Research & Statistics

About 200 reports

Download Unlimited Documents from Trusted Public Sources

View report >

Bliss GVS Pharma Ltd. Company report

  • January 2022
  • 7 pages
  • Africa
  • World
  • Analgesic
  • Financial Services
  • Company research
  • Company
View report >

WuXi AppTec Company report

  • December 2021
  • 5 pages
  • China
  • East Asia
  • Pharmaceutical
  • Laboratory
  • Company research
  • Company
View report >

First REIT Company report

  • December 2021
  • 14 pages
  • Japan
  • Real Estate
  • Financial Services
  • Company research
  • Company
View report >

RHT Capital Pte. Ltd. Company report

  • December 2021
  • 5 pages
  • Singapore
  • Asia
  • Healthcare
  • Financial Services
  • Company research
  • Company
View report >

Shanghai Haohai Biological Technology Co., Ltd. Company report

  • December 2021
  • 11 pages
  • China
  • East Asia
  • Medical Device
  • Ophthalmology
  • Company research
  • Company
  • Medical Devices Sales
View report >

Shalby Ltd Company report

  • October 2021
  • 3 pages
  • India
  • South Asia
  • Hospital
  • Health Services
  • Company research
  • Company
View report >

Idorsia Company report

  • October 2021
  • 7 pages
  • United States
  • World
  • Hospital
  • Neurological Disorder
  • Company research
  • Company
View report >

Dr. Lal PathLabs Company report

  • October 2021
  • 4 pages
  • India
  • South Asia
  • Healthcare
  • Health Services
  • Company research
  • Company
View report >

Greentown Company report

  • October 2021
  • 9 pages
  • Zhejiang
  • China
  • Healthcare
  • Health Services
  • Company research
  • Company
View report >

MSALABS Company report

  • October 2021
  • 4 pages
  • World
  • Tanzania
  • Lead
  • Laboratory
  • Company research
  • Company
  • Foreign Direct Investment


About 100 reports

Purchase Reports From Reputable Market Research Publishers

Company Analysis: Eisai

  • $ 3000
  • January 2021
  • 53 pages

PharmaVitae explores Eisai’s prescription pharmaceutical performance and outlook over 2019–29. Snapshot Overview – Eisai’s growth will continue to be driven by Lenvima in the mid-term, with ...

  • China
  • Dementia
  • Prescription Drug
  • Company research
  • Company

Astellas Company Analysis $ 3000 September 2018


Reportlinker.com © Copyright 2022. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on